We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Orchard Therapeutics plc American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 47 → 0 (-47)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $122M → $0 (-$122M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 47

Holders
–
Holders Change
-47
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
47
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$33.6M
2
BCM
Beryl Capital Management
California
-$25.7M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$14.3M
4
LP
LMR Partners
United Kingdom
-$5.47M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$4.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
DTC
1
Deep Track Capital
Connecticut
– -$33.6M -2,041,670 Closed
BOCH
2
Blue Owl Capital Holdings
New York
– -$2.63M -1,599,660 Closed
BCM
3
Beryl Capital Management
California
– -$25.7M -1,561,499 Closed
Federated Hermes
4
Federated Hermes
Pennsylvania
– -$14.3M -869,327 Closed
LP
5
LMR Partners
United Kingdom
– -$5.47M -332,223 Closed
Tudor Investment Corp
6
Tudor Investment Corp
Connecticut
– -$4.93M -300,000 Closed
Millennium Management
7
Millennium Management
New York
– -$3.93M -238,852 Closed
GF
8
Gabelli Funds
New York
– -$3.69M -224,250 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
– -$3.24M -196,918 Closed
GCIA
10
Gabelli & Co Investment Advisers
New York
– -$3.17M -192,650 Closed
Qube Research & Technologies (QRT)
11
Qube Research & Technologies (QRT)
United Kingdom
– -$2.84M -172,579 Closed
YCM
12
Yakira Capital Management
Connecticut
– -$2.38M -144,826 Closed
Skandinaviska Enskilda Banken (SEB)
13
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$2.31M -140,500 Closed
Goldman Sachs
14
Goldman Sachs
New York
– -$2.26M -137,520 Closed
PCM
15
Prelude Capital Management
New York
– -$1.91M -116,316 Closed
WIC
16
Water Island Capital
New York
– -$1.5M -91,000 Closed
CL
17
CSS LLC
Illinois
– -$1.05M -63,921 Closed
ACM
18
ADAR1 Capital Management
Texas
– -$1.05M -63,622 Closed
BCM
19
BCK Capital Management
Connecticut
– -$718K -43,642 Closed
Jane Street
20
Jane Street
New York
– -$696K -42,291 Closed
Fidelity Investments
21
Fidelity Investments
Massachusetts
– -$678K -41,228 Closed
CG
22
Carmignac Gestion
France
– -$649K -39,468 Closed
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
– -$560K -34,028 Closed
JP Morgan Chase
24
JP Morgan Chase
New York
– -$447K -27,184 Closed
HF
25
HRT Financial
New York
– -$406K -24,737 Closed
1
2

ORTX Hedge Fund Activity: Q1 2024 in Review

0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q1 2024, worth a combined $0 — down 100% from $122M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ORTX and 0 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deep Track Capital, exiting entirely with an estimated $33.6M sold.

  • 0 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q1 2024, down from 47 in Q4 2023.
  • Funds reported $0 of Orchard Therapeutics plc American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q1 2024 and 47 closed out, a net change of -47 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q1 2024 was Deep Track Capital, an estimated $33.6M sold.

Based on aggregated 13F filings for Q1 2024.